-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Edoxaban Tosylate in Chronic Thromboembolic Pulmonary Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Edoxaban Tosylate in Chronic Thromboembolic Pulmonary Hypertension report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Edoxaban Tosylate in Chronic Thromboembolic Pulmonary Hypertension Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Amisulpride in Post Operative Nausea And Vomiting
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Amisulpride in Post Operative Nausea And Vomiting report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Amisulpride in Post Operative Nausea And Vomiting Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SER-155 in Graft Versus Host Disease (GVHD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SER-155 in Graft Versus Host Disease (GVHD) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SER-155 in Graft Versus Host Disease (GVHD) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SER-155 in Bacteremia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SER-155 in Bacteremia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SER-155 in Bacteremia Drug Details: SER-155 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ApoCell in Osteoarthritis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ApoCell in Osteoarthritis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ApoCell in Osteoarthritis Drug Details: ApoCell is under development for the prevention...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Vonoprazan Fumarate in Reflux Esophagitis (Gastroesophageal Reflux Disease)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Vonoprazan Fumarate in Reflux Esophagitis (Gastroesophageal Reflux Disease) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Vonoprazan Fumarate in Reflux Esophagitis (Gastroesophageal Reflux...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Vonoprazan Fumarate in Nonerosive Reflux Disease (NERD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Vonoprazan Fumarate in Nonerosive Reflux Disease (NERD) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Vonoprazan Fumarate in Nonerosive Reflux Disease (NERD) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CRV-101 in Herpes Zoster (Shingles)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CRV-101 in Herpes Zoster (Shingles) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CRV-101 in Herpes Zoster (Shingles) Drug Details: CRV-101 (MG-1120A) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LR-20062 in Pertussis (Whooping Cough)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LR-20062 in Pertussis (Whooping Cough) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LR-20062 in Pertussis (Whooping Cough) Drug Details: LR-20062 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Mosnodenvir in Dengue Fever
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Mosnodenvir in Dengue Fever report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Mosnodenvir in Dengue Fever Drug Details: Mosnodenvir (JNJ-1802) is under development...